Group hypnosis for stress reduction and improved stress coping: a multicenter randomized controlled trial

Table 3 Baseline characteristics (values are means ± standard deviations (SD))

	N	Hypnosis N = 47	Control N = 48	All participants N = 95
		Mean ± SD	Mean ± SD	Mean ± SD
VAS stress level [mm]^a	95	73.8 ± 10.1	69.0 ± 11.3	71.4 ± 10.9
Perceived stress (CPSS score)^a	95	22.5 ± 5.1	22.5 ± 5.9	22.5 ± 5.5
Depression (ADS-K score)^a	95	26.9 ± 7.3	27.9 ± 6.9	27.4 ± 7.1
Self-Efficacy (SWE score)^b	95	26.3 ± 5.3	25.2 ± 4.9	25.7 ± 5.1
SF-36^b
Physical Component Summary^b	95	52.4 ± 10.0	50.7 ± 8.8	51.6 ± 9.4
Mental Component Summary ^b	95	38.0 ± 9.7	38.4 ± 10.5	38.2 ± 10.1
SF-36^b Subscores
Physical functioning	95	90.7 ± 14.7	91.3 ± 10.6	91.0 ± 12.7
Role limitations due to physical health	95	72.3 ± 31.8	71.4 ± 36.8	71.8 ± 34.3
Role limitations due to emotional problems	95	56.0 ± 36.2	61.8 ± 37.7	59.0 ± 36.9
Vitality	95	43.0 ± 17.0	43.1 ± 19.5	43.0 ± 18.2
Emotional well-being	95	56.9 ± 14.8	57.5 ± 15.1	57.2 ± 14.9
Social functioning	95	70.7 ± 23.9	63.0 ± 20.9	66.8 ± 22.7
Pain	95	76.3 ± 28.1	67.9 ± 27.1	72.1 ± 27.8
General health	95	61.2 ± 23.9	59.3 ± 20.6	60.2 ± 22.2

VAS visual analog scale, CPSS Cohen’s Perceived Stress Scale, ADS-K Allgemeine Depressions-Skala Kurzform (depression), SWE Selbstwirksamkeitserwartung (self-efficacy), SF-36 Short-Form-Survey (quality of life)
^a lower values indicate better status, ^b higher values indicate better status

ISSN: 2662-7671